![Martin Bach](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Bach
Direttore operativo presso INVITROCUE LIMITED
Posizioni attive di Martin Bach
Società | Posizione | Inizio | Fine |
---|---|---|---|
INVITROCUE LIMITED | Direttore operativo | 01/05/2016 | - |
Invitrocue Pte Ltd.
![]() Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Direttore operativo | - | - |
Storia della carriera di Martin Bach
Formazione di Martin Bach
Duale Hochschule Baden-Württemberg Villingen-Schwenningen | Masters Business Admin |
Statistiche
Distribuzione geografica
Australia | 2 |
Germania | 2 |
Singapore | 2 |
Posizioni
Chief Operating Officer | 2 |
Masters Business Admin | 1 |
Settori
Health Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Invitrocue Ltd.
![]() Invitrocue Ltd. Medical/Nursing ServicesHealth Services Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia. | Health Services |
Invitrocue Pte Ltd.
![]() Invitrocue Pte Ltd. BiotechnologyHealth Technology Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Martin Bach
- Esperienza